| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1012490237 |
| P356 | DOI | 10.1186/1477-7819-10-171 |
| P932 | PMC publication ID | 3499274 |
| P698 | PubMed publication ID | 22920886 |
| P5875 | ResearchGate publication ID | 230740233 |
| P2093 | author name string | Wei Li | |
| Gang Cao | |||
| Han Liu | |||
| Liang Han | |||
| Junhui Li | |||
| Qingyong Ma | |||
| P2860 | cites work | An animal model of preclinical diagnosis of pancreatic ductal adenocarcinomas | Q84693912 |
| Gestational diabetes as a risk factor for pancreatic cancer: a prospective cohort study | Q21245275 | ||
| New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer | Q24656132 | ||
| The relationship between diabetes and pancreatic cancer | Q24800119 | ||
| Biochemistry and molecular cell biology of diabetic complications | Q28131781 | ||
| Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies | Q28175267 | ||
| Amadori-glycated phosphatidylethanolamine up-regulates telomerase activity in PANC-1 human pancreatic carcinoma cells | Q28270022 | ||
| Pancreatic cancer | Q29616288 | ||
| Clinical epidemiological analysis of the relationship between pancreatic cancer and diabetes mellitus: data from a single institution in China | Q33411513 | ||
| Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry | Q33441700 | ||
| Diabetic ketoacidosis in type 2 diabetics: a novel presentation of pancreatic adenocarcinoma | Q33742521 | ||
| Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals | Q33795313 | ||
| Computational prediction and experimental validation associating FABP-1 and pancreatic adenocarcinoma with diabetes | Q33798621 | ||
| Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer | Q33820455 | ||
| Relationship between neural alteration and perineural invasion in pancreatic cancer patients with hyperglycemia | Q33840959 | ||
| Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells | Q40216291 | ||
| Pancreatic cancer-derived S-100A8 N-terminal peptide: a diabetes cause? | Q40282977 | ||
| Activation of phosphatidylinositol 3-kinase and extracellular signal-regulated kinase is required for glial cell line-derived neurotrophic factor-induced migration and invasion of pancreatic carcinoma cells | Q40529468 | ||
| Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells | Q40538504 | ||
| Pancreatic cancer cells selectively stimulate islet beta cells to secrete amylin | Q41071673 | ||
| Elevated levels of CA 19-9 and CEA in pancreatic cancer-associated diabetes | Q43154547 | ||
| Pancreatic cancer and glucose metabolism | Q43190352 | ||
| Prevalence of pancreatic cancer in diabetics and clinical characteristics of diabetes-associated with pancreatic cancer--comparison between diabetes with and without pancreatic cancer | Q43257972 | ||
| Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds | Q43409626 | ||
| Early changes in islet hormone secretion in the hamster pancreatic cancer model | Q43514550 | ||
| Prevention of pancreatic cancer induction in hamsters by metformin | Q43552285 | ||
| Diabetes enhances growth of pancreatic carcinoma cells. | Q43716306 | ||
| Medically managed hypercholesterolemia and insulin-dependent diabetes mellitus preoperatively predicts poor survival after surgery for pancreatic cancer | Q43855228 | ||
| Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinoma | Q43861519 | ||
| Dysregulation of hepatic superoxide dismutase, catalase and glutathione peroxidase in diabetes: response to insulin and antioxidant therapies | Q44786129 | ||
| Morphometric studies in human pancreatic cancer argues against the etiological role of type 2 diabetes in pancreatic cancer | Q44826950 | ||
| Glucagon/insulin ratio as a potential biomarker for pancreatic cancer in patients with new-onset diabetes mellitus. | Q45942869 | ||
| Polymorphism -23HPhI in the promoter of insulin gene and pancreatic cancer: a pilot study. | Q46157931 | ||
| Beta-cell function and insulin resistance evaluated by HOMA in pancreatic cancer subjects with varying degrees of glucose intolerance | Q46459139 | ||
| Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California | Q46621537 | ||
| Diabetes mellitus in pancreatic cancer: is it a causal relationship? | Q46976065 | ||
| Prevalence of familial pancreatic cancer in Germany | Q49303750 | ||
| Cancer risk associated with insulin glargine among adult type 2 diabetes patients--a nationwide cohort study | Q33954827 | ||
| Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer | Q34023117 | ||
| High glucose promotes pancreatic cancer cell proliferation via the induction of EGF expression and transactivation of EGFR | Q34075493 | ||
| The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth | Q34095570 | ||
| The GDNF/RET signaling pathway and human diseases | Q34360698 | ||
| The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma. | Q34532264 | ||
| The influence of glucose-lowering therapies on cancer risk in type 2 diabetes | Q34609508 | ||
| Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies | Q34625360 | ||
| Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. | Q34722274 | ||
| Risk of malignant neoplasm of the pancreas in relation to diabetes: a population-based study in Taiwan | Q35043728 | ||
| Weight loss precedes cancer-specific symptoms in pancreatic cancer-associated diabetes mellitus | Q35054991 | ||
| New-onset diabetes in pancreatic cancer: a study in the primary care setting | Q35142366 | ||
| Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblasts: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle genes | Q35596741 | ||
| Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity | Q36100858 | ||
| Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer | Q36502937 | ||
| Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. | Q36571182 | ||
| Probability of pancreatic cancer following diabetes: a population-based study | Q36649175 | ||
| Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis | Q36708970 | ||
| Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis | Q36952636 | ||
| Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer | Q37010354 | ||
| Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth | Q37365603 | ||
| Glucose-specific regulation of aldose reductase in capan-1 human pancreatic duct cells In vitro. | Q37372826 | ||
| A cohort study of the risk of cancer associated with type 2 diabetes | Q37400511 | ||
| Diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans | Q37420022 | ||
| Temporal association of changes in fasting blood glucose and body mass index with diagnosis of pancreatic cancer. | Q37426382 | ||
| Pancreatic duct replication is increased with obesity and type 2 diabetes in humans | Q37463887 | ||
| Obesity related hyperinsulinaemia and hyperglycaemia and cancer development | Q37503147 | ||
| Glucose metabolism gene variants modulate the risk of pancreatic cancer | Q37671201 | ||
| Diabetes mellitus type 2 - an independent risk factor for cancer? | Q37686371 | ||
| Diabetes and pancreatic cancer: chicken or egg? | Q37853809 | ||
| Hyperglycemia enhances the invasive and migratory activity of pancreatic cancer cells via hydrogen peroxide | Q39605380 | ||
| Expression of antioxidant enzymes in diseases of the human pancreas: another link between chronic pancreatitis and pancreatic cancer | Q39638465 | ||
| High glucose promotes cell proliferation and enhances GDNF and RET expression in pancreatic cancer cells | Q39642080 | ||
| Altered intracellular calcium fluxes in pancreatic cancer induced diabetes mellitus: Relevance of the S100A8 N-terminal peptide (NT-S100A8). | Q39666332 | ||
| Predictive factors in pancreatic ductal adenocarcinoma: role of the inflammatory response. | Q40212563 | ||
| Portal but not peripheral serum levels of interleukin 6 could interfere with glucose metabolism in patients with pancreatic cancer. | Q51566173 | ||
| Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. | Q51599459 | ||
| Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias. | Q53086583 | ||
| New-onset diabetes with a history of dyslipidemia predicts pancreatic cancer. | Q53102072 | ||
| Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor? | Q54252640 | ||
| Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. | Q54374951 | ||
| Novel blood biomarkers of pancreatic cancer-associated diabetes mellitus identified by peripheral blood-based gene expression profiles. | Q54422958 | ||
| Diabetes and the Risk of Pancreatic Cancer | Q60023737 | ||
| The contribution of fructose and nitric oxide to oxidative stress in hamster islet tumor (HIT) cells through the inactivation of glutathione peroxidase | Q73449264 | ||
| The intracellular mechanism of insulin resistance in pancreatic cancer patients | Q73555623 | ||
| Improved survival in small pancreatic cancer | Q73599217 | ||
| A prospective pancreatographic study of the prevalence of pancreatic carcinoma in patients with diabetes mellitus | Q74116694 | ||
| Differential expression of RAGE in human pancreatic carcinoma cells | Q77552948 | ||
| The association between selected risk factors for pancreatic cancer and the expression of p53 and K-ras codon 12 mutations | Q80122380 | ||
| Hyperglycemia promotes the perineural invasion in pancreatic cancer | Q81503531 | ||
| Fasting serum glucose level and cancer risk in Korean men and women | Q81734745 | ||
| Upregulation of REG Ialpha accelerates tumor progression in pancreatic cancer with diabetes | Q82636716 | ||
| Risk factors of familial pancreatic cancer in Japan: current smoking and recent onset of diabetes | Q83843604 | ||
| Amadori-glycated phosphatidylethanolamine, a potential marker for hyperglycemia, in streptozotocin-induced diabetic rats | Q84511147 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreatic cancer | Q212961 |
| type 2 diabetes | Q3025883 | ||
| complications of diabetes mellitus | Q4198677 | ||
| pancreatic neoplasm | Q7130412 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 171 | |
| P577 | publication date | 2012-08-24 | |
| P1433 | published in | World Journal of Surgical Oncology | Q14520241 |
| P1476 | title | The bidirectional interation between pancreatic cancer and diabetes | |
| P478 | volume | 10 |
| Q38467334 | Analysis of global gene expression profiles suggests a role of acute inflammation in type 3C diabetes mellitus caused by pancreatic ductal adenocarcinoma |
| Q33598407 | Association of elevated risk of pancreatic cancer in diabetic patients: A systematic review and meta-analysis |
| Q37709777 | Diabetic ketoacidosis as the presenting manifestation of pancreatic adenocarcinoma with cystic features. |
| Q34645978 | Discovering the route from inflammation to pancreatic cancer |
| Q64041998 | Familial Pancreatic Ductal Adenocarcinoma |
| Q36477188 | Glycemic Variation in Tumor Patients with Total Parenteral Nutrition |
| Q37084377 | Hyperglycemia Promotes the Epithelial-Mesenchymal Transition of Pancreatic Cancer via Hydrogen Peroxide |
| Q37547661 | Lactate, a Neglected Factor for Diabetes and Cancer Interaction. |
| Q89149100 | Pancreatic Cancer Following Incident Diabetes in African Americans and Latinos: The Multiethnic Cohort |
| Q33941378 | Preoperative glucose abnormalities in patients with pancreatic tumours |
| Q98771767 | Survival Benefit of Metformin Use for Pancreatic Cancer Patients Who Underwent Pancreatectomy: Results From a Meta-Analysis |
| Q63372075 | The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma |
| Q90398573 | The relationship between pancreatic cancer and type 2 diabetes: cause and consequence |
Search more.